A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected

Raquel Gonzalez and colleagues highlight an urgent need to evaluate antimalarials that can be safely administered to HIV-infected pregnant women on antiretroviral treatment and cotrimoxazole prophylaxis.

[1]  K. Salifou,et al.  Determinants of Adherence to Intermittent Preventive Treatment for Malaria with Sulfadoxine Pyrimethamine (IPTp-SP) in Pregnant Women in Parakou (BENIN) , 2016 .

[2]  K. Na-Bangchang,et al.  Pharmacokinetic Interactions Between Quinine and Lopinavir/Ritonavir in Healthy Thai Adults. , 2015, The American journal of tropical medicine and hygiene.

[3]  K. Na-Bangchang,et al.  Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults , 2015, Malaria Journal.

[4]  M. Molyneux,et al.  Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection , 2015, mBio.

[5]  C. Menéndez,et al.  Malaria in pregnancy: challenges for control and the need for urgent action. , 2015, The Lancet. Global health.

[6]  F. Nosten,et al.  Opposite malaria and pregnancy effect on oral bioavailability of artesunate – a population pharmacokinetic evaluation , 2015, British journal of clinical pharmacology.

[7]  S. Abdulla,et al.  Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo-Controlled Trial , 2014, PLoS medicine.

[8]  B. Ngasala,et al.  Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality , 2014, BMC Pharmacology and Toxicology.

[9]  E. Kendjo,et al.  Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  N. Isoherranen,et al.  Drug Metabolism and Transport During Pregnancy: How Does Drug Disposition Change during Pregnancy and What Are the Mechanisms that Cause Such Changes? , 2013, Drug Metabolism and Disposition.

[11]  A. Bennett,et al.  Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. , 2012, The Lancet. Infectious diseases.

[12]  C. Menéndez,et al.  HIV and malaria interactions: where do we stand? , 2012, Expert review of anti-infective therapy.

[13]  S. Meshnick,et al.  Marked Reduction in Prevalence of Malaria Parasitemia and Anemia in HIV-Infected Pregnant Women Taking Cotrimoxazole With Or Without Sulfadoxine-Pyrimethamine Intermittent Preventive Therapy during Pregnancy in Malawi , 2011, The Journal of infectious diseases.

[14]  C. Menéndez,et al.  Cost-Effectiveness of Intermittent Preventive Treatment of Malaria in Pregnancy in Southern Mozambique , 2010, PloS one.

[15]  A. Tatem,et al.  Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study , 2010, PLoS medicine.

[16]  Doris Ma Fat,et al.  WHO Library Cataloguing-in-Publication Data , 2001 .

[17]  HighWire Press,et al.  Drug metabolism and disposition : the biological fate of chemicals. , 1973 .